The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 28523109 |
79 |
Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4. |
Glaxosmithkline |
| 24881566 |
140 |
Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120). |
Glaxosmithkline |
| 23886683 |
54 |
The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophore. |
Glaxosmithkline |
| 30943030 |
97 |
Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases. |
University of Nebraska Medical Center |
| 30335378 |
25 |
Discovery of Pyrrolidine Sulfonamides as Selective and Orally Bioavailable Antagonists of Transient Receptor Potential Vanilloid-4 (TRPV4). |
TBA |
| 28395140 |
25 |
Pyrazolopyrimidines as Potent Stimulators for Transient Receptor Potential Canonical 3/6/7 Channels. |
Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Moe) and Hubei Provinc |
Search and Browse
